Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Idiopathic interstitial pneumonias (IIPs) have a progressive and often fatal course, and their enigmatic etiology has complicated approaches to effective therapies. Idiopathic pulmonary fibrosis (IPF) is the most common of IIPs and shares with IIPs an increased incidence with age and unexplained scarring in the lung. Short telomeres limit tissue renewal capacity in the lung and germ-line mutations in telomerase components, hTERT and hTR , underlie inheritance in a subset of families with IPF. To examine the hypothesis that short telomeres contribute to disease risk in sporadic IIPs, we recruited patients who have no family history and examined telomere length in leukocytes and in alveolar cells. To screen for mutations, we sequenced hTERT and hTR. We also reviewed the cases for features of a telomere syndrome. IIP patients had shorter leukocyte telomeres than age-matched controls ( P < 0.0001). In a subset (10%), IIP patients had telomere lengths below the first percentile for their age. Similar to familial cases with mutations, IPF patients had short telomeres in alveolar epithelial cells ( P < 0.0001). Although telomerase mutations were rare, detected in 1 of 100 patients, we identified a cluster of individuals (3%) with IPF and cryptogenic liver cirrhosis, another feature of a telomere syndrome. Short telomeres are thus a signature in IIPs and likely play a role in their age-related onset. The clustering of cryptogenic liver cirrhosis with IPF suggests that the telomere shortening we identify has consequences and can contribute to what appears clinically as idiopathic progressive organ failure in the lung and the liver.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, patients with IPF who have mutant telomerase genes are at an increased risk of developing bone marrow failure and liver disease54,71.”
From The telomere syndromes (2012) · cites this paper as [54]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, telomere dysfunction in epithelial cells, or perhaps another cell type, might cause parenchymal organ remodelling, which manifests as fibrosis and/or emphysema46,54,99.”
From The telomere syndromes (2012) · cites this paper as [54]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Moreover, circulating leukocytes and alveolar epithelial cells show shorter telomeres than age-matched individuals53.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [53]
The cited source says what the claim attributes to it.
In the citing paper
“The frequency of these mutations is highest in individuals with the progressive disorder IPF, which accounts for 8–15% of familial and 1–3% of sporadic cases54,56,68,69.”
From The telomere syndromes (2012) · cites this paper as [54]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Lead SNPs at two loci (TERC and TERT) associate with several cancers and other diseases, including idiopathic pulmonary fibrosis.”
From Identification of seven loci affecting mean telomere length and their association with disease (2013) · cites this paper as [26]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 6×
“In IPF families with telomerase mutations, cases of aplastic anemia can be hidden and are uncovered after a thorough family history, suggesting that mutations in telomerase have heterogeneous manifestations in an individual patient and within families, and that a subset of families with IPF falls on the same spectrum…”
BackgroundInfluentialSelf-citationEssential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270
A telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168
Greider, C. W., & Blackburn, E. H. (1987) · Cell · doi:10.1016/0092-8674(87)90576-9 · Cited by 1,150
Cited by
Items 201–300 of 802
Risk Factors for the Development of Idiopathic Pulmonary Fibrosis: a Review
Zaman, T., & Lee, J. S. (2018) · Current Pulmonology Reports · doi:10.1007/s13665-018-0210-7 · Cited by 96
Connective tissue diseases, multimorbidity and the ageing lung
Spagnolo, P., Cordier, J.-F., & Cottin, V. (2016) · European Respiratory Journal · doi:10.1183/13993003.00829-2015 · Cited by 95
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease
Zhang, D., Adegunsoye, A., Oldham, J. M., Kozlitina, J., Garcia, N. M., Poonawalla, M., Strykowski, R. K., Linderholm, A., Ley, B., Ma, S., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00441-2023 · Cited by 95
Evaluation and management of pulmonary disease in ataxia‐telangiectasia
McGrath‐Morrow, S. A., Gower, W. A., Rothblum‐Oviatt, C., Brody, A. S., Langston, C., Fan, L. L., Lefton‐Greif, M. A., Crawford, T. O., Troche, M. S., Sandlund, J. T., et al. (2010) · Pediatric Pulmonology · doi:10.1002/ppul.21277 · Cited by 93
Telomerase and Telomere Length in Pulmonary Fibrosis
Liu, T., Ullenbruch, M., Young Choi, Y., Yu, H., Ding, L., Xaubet, A., Pereda, J., Feghali-Bostwick, C. A., Bitterman, P. B., Henke, C. A., et al. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0514oc · Cited by 83
Lung Transplant Outcomes in Patients With Pulmonary Fibrosis With Telomere-Related Gene Variants
Swaminathan, A. C., Neely, M. L., Frankel, C. W., Kelly, F. L., Petrovski, S., Durheim, M. T., Bush, E., Snyder, L. D., Goldstein, D. B., Todd, J. L., et al. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.03.030 · Cited by 85
Genetic determinants of pulmonary fibrosis: evolving concepts
Spagnolo, P., Grünewald, J., & du Bois, R. M. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70047-5 · Cited by 89
Le Saux, C. J., Davy, P., Brampton, C., Ahuja, S. S., Fauce, S., Shivshankar, P., Nguyen, H., Ramaseshan, M., Tressler, R., Pirot, Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058423 · Cited by 82
“Within the past decade, a number of diseases or conditions have been associated with mutations in telomerase and/or accelerated telomere loss, including AIDS [7], dyskeratosis congenita [8,9], aplastic anemia [10] and idiopathic pulmonary fibrosis (IPF) [11,12,13].”
BackgroundResultInfluentialVarma, S., Cao, Y., Tagne, J.-B., Lakshminarayanan, M., Li, J., Friedman, T. B., Morell, R. J., Warburton, D., Kotton, D. N., & Ramirez, M. I. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.408401 · Cited by 79
Coghlan, M. A., Shifren, A., Huang, H. J., Russell, T. D., Mitra, R. D., Zhang, Q., Wegner, D. J., Cole, F. S., & Hamvas, A. (2014) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2014-000057 · Cited by 80
Molecular programs of fibrotic change in aging human lung
Lee, S., Islam, M. N., Boostanpour, K., Aran, D., Jin, G., Christenson, S., Matthay, M. A., Eckalbar, W. L., DePianto, D. J., Arron, J. R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26603-2 · Cited by 78
Idiopathic Pulmonary Fibrosis—an Epidemiological and Pathological Review
Borchers, A. T., Chang, C. C., Keen, C. L., & Gershwin, M. E. (2010) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8211-5 · Cited by 87
“Telomerase mutations were identified in only 1–3% of patients with sporadic IPF [37–39].”
BackgroundResultPulmonary fibrosis in the era of stratified medicine
Mathai, S. K., Newton, C. A., Schwartz, D. A., & Garcia, C. K. (2016) · Thorax · doi:10.1136/thoraxjnl-2016-209172 · Cited by 77
Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis.
Chilosi, M., Doglioni, C., Murer, B., & Poletti, V. E. (2010) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 90
Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions
Stainer, A., Faverio, P., Busnelli, S., Catalano, M., Della Zoppa, M., Marruchella, A., Pesci, A., & Luppi, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126255 · Cited by 76
“Although the telomerase complex can be evaluated on blood cells (granulocytes or monocytes), and common in IPF patients compared with age matched controls [39], it is globally rare in sporadic IPF and not specific since it has been associated with risk of developing chronic obstructive pulmonary disease (COPD) too [40…”
BackgroundLung alveolar integrity is compromised by telomere shortening in telomerase-null mice
Lee, J., Reddy, R., Barsky, L., Scholes, J., Chen, H., Shi, W., & Driscoll, B. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90411.2008 · Cited by 75
“Indeed, activation of all MAPK pathways, with specific pathways activated in specific cell types, has been observed in patients with IPF (67).”
BackgroundSmoking‐related idiopathic interstitial pneumonia: A review
Margaritopoulos, G. A., Harari, S. A., Caminati, A., & Antoniou, K. M. (2015) · Respirology · doi:10.1111/resp.12576 · Cited by 81
Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine
Spagnolo, P., & Cottin, V. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103973 · Cited by 82
Epithelial Injury and Dysfunction in the Pathogenesis of Idiopathic PulmonaryFibrosis
Winters, N. I., Burman, A., Kropski, J. A., & Blackwell, T. S. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.01.010 · Cited by 76
Adegunsoye, A., Kropski, J. A., Behr, J., Blackwell, T. S., Corte, T. J., Cottin, V., Glanville, A. R., Glassberg, M. K., Griese, M., Hunninghake, G. M., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202401-0238so · Cited by 97
Xie, M., Podlevsky, J. D., Qi, X., Bley, C. J., & Chen, J. J. ‐. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1198 · Cited by 78
“Telomerase reconstituted in vitro or in cells was assayed using the conventional direct primer-extension assay as previously described (30), with the exception of that 0.”
Self-citationSivley, R. M., Kropski, J., Sheehan, J., Cogan, J., Dou, X., Blackwell, T. S., Phillips, J., Meiler, J., Bush, W. S., & Capra, J. A. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.01.017 · Cited by 79
Self-citationDeterminants of initiation and progression of idiopathic pulmonary fibrosis
Kottmann, R. M., Hogan, C. M., Phipps, R. P., & Sime, P. J. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01624.x · Cited by 74
Many disease-associated variants of hTERT retain high telomerase enzymatic activity
Zaug, A. J., Crary, S. M., Fioravanti, M. J., Campbell, K. P., & Cech, T. R. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt653 · Cited by 82
Is Progression of Pulmonary Fibrosis due to Ventilation-induced Lung Injury?
Albert, R. K., Smith, B. J., Perlman, C. E., & Schwartz, D. A. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0497pp · Cited by 79
Yanagi, S., Tsubouchi, H., Miura, A., Matsumoto, N., & Nakazato, M. (2015) · BioMed Research International · doi:10.1155/2015/573210 · Cited by 71
Endothelin in Pulmonary Fibrosis
Fonseca, C., Abraham, D., & Renzoni, E. A. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0388tr · Cited by 70
Targeting telomerase for its advent in cancer therapeutics
Bajaj, S., Kumar, M. S., Peters, G. J., & Mayur, Y. (2020) · Medicinal Research Reviews · doi:10.1002/med.21674 · Cited by 78
Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease
Adegunsoye, A., Vij, R., & Noth, I. (2019) · CHEST Journal · doi:10.1016/j.chest.2018.12.011 · Cited by 80
Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs
Hadjicharalambous, M. R., & Lindsay, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020524 · Cited by 75
“Interestingly, IPF as been asso iated with telomere shortening [75], although the exact mechanisms that links this to the fibrotic response are still unclear.”
BackgroundIdiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night
Schiza, S. E., Mermigkis, C. M., Margaritopoulos, G. A., Daniil, Z. D., Harari, S. A., Poletti, V. E., Renzoni, E. A., Torre, O., Visca, D., Bouloukaki, I., et al. (2015) · European Respiratory Review · doi:10.1183/16000617.00009114 · Cited by 76
Short lung transplant donor telomere length is associated with decreased CLAD-free survival
Faust, H. E., Golden, J. A., Rajalingam, R., Wang, A. S., Green, G., Hays, S. R., Kukreja, J., Singer, J. P., Wolters, P. J., & Greenland, J. R. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209897 · Cited by 70
Dyskeratosis congenita: The first NIH clinical research workshop
Savage, S. A., Dokal, I. S., Armanios, M. Y., Aubert, G., Cowen, E. W., Domingo, D. L., Giri, N., Greene, M. H., Orchard, P. J., Tolar, J., et al. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22061 · Cited by 69
“TERT and TERC mutations have been found in patients with pulmonary fibrosis and patients with apparently acquired aplastic anemia; these patients did not have the classic triad of DC [23,18,24,25].”
BackgroundSelf-citationYanagi, S., Tsubouchi, H., Miura, A., Matsuo, A., Matsumoto, N., & Nakazato, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030503 · Cited by 80
The genetics of interstitial lung diseases
Borie, R., Guen, P. L., Ghanem, M., Taillé, C., Dupin, C., Dieudé, P., Kannengiesser, C., & Crestani, B. (2019) · European Respiratory Review · doi:10.1183/16000617.0053-2019 · Cited by 79
Telomere Dysfunction and Cell Senescence in Chronic Lung Diseases: Therapeutic Potential
Adnot, S., Amsellem, V., Boyer, L., Marcos, É., Saker, M., Houssaini, A., Kebe, K., Dagouassat, M., Lipskaia, L., & Boczkowski, J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.007 · Cited by 72
Matson, S. M., Lee, J. S., & Eickelberg, O. (2020) · European Respiratory Journal · doi:10.1183/13993003.02533-2020 · Cited by 81
NADPH oxidases: Pathophysiology and therapeutic potential in age-associated pulmonary fibrosis
Kato, K., & Hecker, L. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101541 · Cited by 70
Pulmonary phenotypes associated with genetic variation in telomere-related genes
Hoffman, T. W., van Moorsel, C. H. M., Borie, R., & Crestani, B. (2018) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000475 · Cited by 70
Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita
Parry, E. M., Alder, J. K., Lee, S. S., Phillips, J. A., Loyd, J. E., Duggal, P., & Armanios, M. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2010.085100 · Cited by 66
“Since females in X-linked DC have been previously described to have skewed X-inactivation,”
BackgroundSelf-citationThe Age of Idiopathic Pulmonary Fibrosis
Collard, H. R. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0049ed · Cited by 75
Telomere Length Maintenance, Shortening, and Lengthening
Zhao, Z., Pan, X., Liu, L., & Liu, N. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24537 · Cited by 66
“Sporadic IPF is the very case (those who report no family history) that have significantly shorter telomeres than age-matched controls with intact telomerase (Alder et al., 2008; Cronkhite et al., 2008).”
BackgroundSenescence and tissue fibrosis: opportunities for therapeutic targeting
O’Reilly, S., Tsou, P., & Varga, J. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.05.012 · Cited by 72
Epigenetics in lung fibrosis: from pathobiology to treatment perspective
Helling, B. A., & Yang, I. V. (2015) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000191 · Cited by 70
The Spectrum of Hepatic Involvement in Patients With Telomere Disease
Kapuria, D., Yakov, G. B., Ortolano, R., Cho, M. H., Kalchiem‐Dekel, O., Takyar, V. K., Lingala, S., Gara, N., Tana, M. M.-S., Kim, Y. J., et al. (2019) · Hepatology · doi:10.1002/hep.30578 · Cited by 71
Schratz, K. E., Flasch, D. A., Atik, C. C., Cosner, Z. L., Blackford, A. L., Yang, W., Gable, D. L., Vellanki, P. J., Xiang, Z., Gaysinskaya, V. A., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.03.005 · Cited by 71
Self-citationChung, E. J., Kwon, S., Reedy, J. L., White, A. O., Song, J. S., Hwang, I., Chung, J., Ylaya, K., Hewitt, S. M., & Citrin, D. E. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.12.035 · Cited by 66
A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung Abnormalities
Moll, M. R., Peljto, A. L., Kim, J. S., Xu, H., Debban, C. L., Chen, X., Menon, A. A., Putman, R. K., Ghosh, A., Saferali, A., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202212-2257oc · Cited by 80
Courtwright, A., Lamattina, A. M., Takahashi, M., Trindade, A. J., Hunninghake, G. M., Rosas, I. O., Agarwal, S., Raby, B. A., Goldberg, H. J., & El‐Chemaly, S. (2020) · ERJ Open Research · doi:10.1183/23120541.00003-2020 · Cited by 62
Adegunsoye, A., Newton, C. A., Oldham, J. M., Ley, B., Lee, C. T., Linderholm, A., Chung, J. H., Garcia, N. M., Zhang, D., Vij, R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37193-6 · Cited by 65
New Insights into the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis
Ding, Q., Luckhardt, T., Hecker, L., Zhou, Y., Liu, G., Antony, V. B., deAndrade, J. A., & Thannickal, V. J. (2011) · Drugs · doi:10.2165/11591490-000000000-00000 · Cited by 68
“Several recent studies have suggested multiple biomarkers that might be useful in distinguishing IPF patients from those with other lung diseases and healthy controls such as the major histocompatibility complex class I chain-related geneA (MICA) polymorphisms,([182])MMP-1,([183,184]) MMP-7,([184]) oxidative stress([1…”
BackgroundTelomerase treatment prevents lung profibrotic pathologies associated with physiological aging
Piñeiro-Hermida, S., Autilio, C., Martínez, P., Bosch, F., Pérez-Gil, J., & Blasco, M. A. (2020) · Journal of Cell Biology · doi:10.1083/jcb.202002120 · Cited by 60
“In agreement with IPF being an age-associated disease, IPF patients present most of the hallmarks of aging including abnormal shortening of telomeres, genomic instability, mitochondrial dysfunction, increased oxidative stress, and senescence (Meiners et al., 2015; Selman and Pardo, 2014; Alder et al., 2008; Demopoulos…”
BackgroundInfluentialLawson, W. E., Loyd, J. E., & Degryse, A. L. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31821a9d7a · Cited by 66
Self-citationThe Role of Genetic Testing in Pulmonary Fibrosis
Newton, C. A., Oldham, J. M., Applegate, C. D., Carmichael, N. E., Powell, K. P., Dilling, D. F., Schmidt, S. L., Scholand, M. B., Armanios, M. Y., Garcia, C. K., et al. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.03.023 · Cited by 68
Self-citationLuo, F., Zhuang, Y., Sides, M. D., Sanchez, C. G., Shan, B., White, E. S., & Lasky, J. A. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-51 · Cited by 66
Targeting Alveolar Repair in Idiopathic Pulmonary Fibrosis
Ptasinski, V., Stegmayr, J., Belvisi, M. G., Wagner, D. E., & Murray, L. A. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0476tr · Cited by 65
“Short telomeres have been found both in cases of familial IPF (65) and in cases of sporadic IPF (66).”
BackgroundZhang, D., & Newton, C. A. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.06.037 · Cited by 72
Novel therapeutic strategies for lung disorders associated with airway remodelling and fibrosis
Royce, S. G., Moodley, Y. P., & Samuel, C. S. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.008 · Cited by 66
Alder, J. K., Sutton, R. M., Iasella, C. J., Nouraie, M. S., Koshy, R., Hannan, S. J., Chan, E. G., Chen, X., Zhang, Y., Brown, M. J., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.11.008 · Cited by 61
Self-citationStanley, S. E., Merck, S. J., & Armanios, M. Y. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201609-718aw · Cited by 58
Self-citationBenyelles, M., O’Donohue, M.-F., Kermasson, L., Lainey, E., Borie, R., Lagresle-Peyrou, C., Nunes, H., Cazelles, C., Fourrage, C., Ollivier, E., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa011 · Cited by 58
The mitochondria in lung fibrosis: friend or foe?
Malsin, E. S., & Kamp, D. W. (2018) · Translational research · doi:10.1016/j.trsl.2018.05.005 · Cited by 58
“This is well illustrated in IPF and inherited forms of pulmonary fibrosis in which, compared to age-matched healthy controls, shortened telomeres are evident, especially in AT2 cells.(6,190,191) Telomere dysfunction can also further alter mitochondrial biogenesis via telomere-p53-peroxisome proliferator-activated rece…”
BackgroundLiu, T., Santos, F. G. D. L., Zhao, Y., Wu, Z. B., Rinke, A. E., Kim, K. K., & Phan, S. H. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006615 · Cited by 59
“Mutant TERT, TR, and/or shortened telomeres in peripheral blood leukocytes are amply documented as risk factors for idiopathic pulmonary fibrosis (IPF) (3, 4, 20, 21).”
BackgroundQiu, T., Tian, Y., Gao, Y., Ma, M., Li, H., Liu, X., Wu, H., Zhang, Y., Ding, H. J., Cao, M., et al. (2019) · Aging · doi:10.18632/aging.102262 · Cited by 64
“Aging is considered the main risk factor for IPF [6].”
BackgroundSelf-citationHambly, N., Shimbori, C., & Kolb, M. (2015) · Respirology · doi:10.1111/resp.12569 · Cited by 55
Cryptogenic Cirrhosis: What Are We Missing?
Caldwell, S. H. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-009-0082-7 · Cited by 60
“Cryptogenic cirrhosis has also been described in a patient with hypocholesterolemia and an abnormal truncated form of apolipoprotein B and in families afflicted with short telomere syndromes associated with pulmonary fibrosis [74, 75 ].”
BackgroundTelomerase deficiency does not alter bleomycin-induced fibrosis in mice
Degryse, A. L., Xu, X. C., Newman, J. L., Mitchell, D. B., Tanjore, H., Polosukhin, V. V., Jones, B. R., McMahon, F. B., Gleaves, L. A., Phillips, J. A., et al. (2012) · Experimental Lung Research · doi:10.3109/01902148.2012.658148 · Cited by 54
“In fact, subsequent studies of cases of IPF indicate that telomere shortening is prominent even in the absence of TERC or TERT mutations [30, 31], suggesting the potential for a common role for telomerase dysfunction in IPF [4].”
Self-citationThe aging lung: tissue telomere shortening in health and disease
Everaerts, S., Lammertyn, E. J., Martens, D. S., Sadeleer, L. D., Maes, K., van Batenburg, A. A., Goldschmeding, R., van Moorsel, C. H. M., Dupont, L., Wuyts, W. A., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0794-z · Cited by 57
“Unfortunately, this study lacks data of explanted IPF lungs, which is -at least partly- a disease of deficient telomere maintenance [14, 44].”
BackgroundClinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF)
Krauss, E., Gehrken, G. V., Drakopanagiotakis, F., Tello, S., Dartsch, R. C., Maurer, O., Windhorst, A., von der Beck, D., Griese, M., Seeger, W., et al. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0895-6 · Cited by 65
Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into Immunopathogenesis
Michalski, J. E., & Schwartz, D. A. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s280958 · Cited by 67
Telomere and telomerase in chronic liver disease and hepatocarcinoma
Carulli, L., & Anzivino, C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i20.6287 · Cited by 57
Bender, H. S., Murchison, E. P., Pickett, H. A., Deakin, J. E., Strong, M. A., Conlan, C., McMillan, D. A., Neumann, A. A., Greider, C. W., Hannon, G. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046195 · Cited by 60
“The importance of protecting telomere integrity is evident in the diverse spectrum of human disease associated with telomere dysfunction, from neoplasia to pulmonary fibrosis and bone marrow failure [15–18].”
What have we learned from basic science studies on idiopathic pulmonary fibrosis?
Yanagihara, T., Sato, S., Upagupta, C., & Kolb, M. (2019) · European Respiratory Review · doi:10.1183/16000617.0029-2019 · Cited by 53
Lung alveolar epithelium and interstitial lung disease
Corvol, H., Flamein, F., Epaud, R., Clément, A., & Guillot, L. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.02.009 · Cited by 59
Juge, P., Solomon, J. J., van Moorsel, C. H. M., Garofoli, R., Lee, J. S., Louis‐Sidney, F., Rojas‐Serrano, J., González-Pérez, M. I., Mejía, M. E., Buendía-Roldán, I., et al. (2021) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2021.07.002 · Cited by 54
Tirelli, C., Pesenti, C., Miozzo, M. R., Mondoni, M., Fontana, L., & Centanni, S. (2022) · Diagnostics · doi:10.3390/diagnostics12123107 · Cited by 57
Mendoza-Milla, C., Jiménez, A. V., Rangel‐Escareño, C., Lozano, A., Morales, V., Becerril, C., Chavira, R., Ruiz, V., Barrera, L., Montaño, M., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00027412 · Cited by 56
Human telomerase expression regulation
Machnik, M., Wojtyla, A., & Rubiś, B. (2011) · Biochemistry and Cell Biology · doi:10.1139/o11-037 · Cited by 62
Bae, W., Lee, C., Lee, J., Kim, Y. W., Han, K., & Choi, S. M. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-215386 · Cited by 59
The relationship between telomere length and aging-related diseases
Huang, X., Huang, L., Lu, J., Cheng, L., Wu, D. A., Li, L., Zhang, S., Lai, X., & Xu, L. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01608-z · Cited by 64
“A study comparing TL in alveolar epithelial cells from individuals with normal lung function, sporadic IPF, and IPF with telomerase mutations found that both IPF groups had significantly shorter telomeres than healthy controls [94].”
Borie, R., Kannengiesser, C., Nathan, N., Tabèze, L., Pradère, P., & Crestani, B. (2014) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2014.07.017 · Cited by 58
Donati, B., Pietrelli, A., Pingitore, P., Dongiovanni, P., Caddeo, A., Walker, L., Baselli, G., Pelusi, S., Rosso, C., Vanni, E., et al. (2017) · Cancer Medicine · doi:10.1002/cam4.1078 · Cited by 52
Liu, Y., Shi, Y., Liu, Y., Pan, X., & Zhang, K. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0007-9 · Cited by 57
Lee, J. S., La, J. L., Aziz, S., Dobrinskikh, E., Brownell, R., Jones, K. D., Achtar‐Zadeh, N., Green, G., Elicker, B. M., Golden, J. A., et al. (2021) · Histopathology · doi:10.1111/his.14334 · Cited by 58
Okuda, R., Aoshiba, K., Matsushima, H., Ogura, T., Okudela, K., & Ohashi, K. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.02.11 · Cited by 52
“Previous studies have reported an enhanced cellular senescence in lung disorders, including chronic obstructive pulmonary disease (COPD) (6) and idiopathic pulmonary fibrosis (IPF) (7,8).”
BackgroundGeorge, G., Rosas, I. O., Cui, Y., McKane, C. K., Hunninghake, G. M., Camp, P. C., Raby, B. A., Goldberg, H. J., & El‐Chemaly, S. (2014) · CHEST Journal · doi:10.1378/chest.14-0631 · Cited by 50
Epigenomics of Idiopathic Pulmonary Fibrosis
Yang, I. V. (2012) · Epigenomics · doi:10.2217/epi.12.10 · Cited by 53
Combined pulmonary fibrosis and emphysema: The many aspects of a cohabitation contract
Papaioannou, A. Ι., Κostikas, Κ., Manali, E. D., Papadaki, G. F., Roussou, A., Kolilekas, L., Borie, R., Bouros, D. E., & Papiris, S. A. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.05.005 · Cited by 50
A role for telomere length and chromosomal damage in idiopathic pulmonary fibrosis
McDonough, J. E., Martens, D. S., Tanabe, N., Ahangari, F., Verleden, S. E., Maes, K., Verleden, G. M., Kaminski, N., Hogg, J. C., Nawrot, T. S., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0838-4 · Cited by 49
Precision Approaches to Chronic Obstructive Pulmonary Disease Management
Moll, M. R., & Silverman, E. K. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-060622-101239 · Cited by 54
Translational research in pulmonary fibrosis
Mathai, S. K., & Schwartz, D. A. (2019) · Translational research · doi:10.1016/j.trsl.2019.02.001 · Cited by 53
Tomos, I. P., Dimakopoulou, K., Manali, E. D., Papiris, S. A., & Karakatsani, A. (2021) · Environmental Health · doi:10.1186/s12940-021-00786-z · Cited by 53
Telomere Dysfunction in Idiopathic Pulmonary Fibrosis
Zhang, K., Xu, L., & Cong, Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.739810 · Cited by 63
“Intriguingly, overall, as many as 37% of familial IPF and 25% of sporadic IPF cases have shorter telomeres, whereas as many as 24% of familial IPF and 23% of sporadic IPF cases without TERT or TERCmutations also have significantly short telomeres, suggesting the existence of other gene mutations in IPF (25, 26).”
BackgroundRegulation of TERRA on telomeric and mitochondrial functions in IPF pathogenesis
Gao, Y., Zhang, J., Liu, Y., Zhang, S., Wang, Y., Liu, B., Liu, H., Li, R., Lv, C., & Song, X. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0516-1 · Cited by 46
“In particular, genetic and clinical evidence indicates that short telomere phenotype appears in most IPF patients [37, 38].”
BackgroundToll interacting protein protects bronchial epithelial cells from bleomycin‐induced apoptosis
Li, X., Kim, S. E., Chen, T., Wang, J., Yang, X., Tabib, T., Tan, J., Guo, B., Fung, S., Zhao, J., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902636rr · Cited by 46
Self-citationTelomere Shortening and Its Association with Cell Dysfunction in Lung Diseases
Ruíz, A., Flores‐González, J., Buendía-Roldán, I., & Chávez‐Galán, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010425 · Cited by 49
“Moreover, it increases epithelial cell apoptosis; in particular, FPF patients exhibiting TS have a worse prognosis and high morbidity after lung transplantation than those without TS [64,75].”
BackgroundNatural History of Pulmonary Fibrosis in Two Subjects With the Same Telomerase Mutation
El‐Chemaly, S., Ziegler, S. G., Calado, R. T., Wilson, K. A., Wu, H. P., Haughey, M., Peterson, N. R., Young, N. S., Gahl, W. A., Moss, J., et al. (2010) · CHEST Journal · doi:10.1378/chest.10-2048 · Cited by 48
The role of cellular senescence in aging through the prism of Koch-like criteria
Yanai, H., & Fraifeld, V. E. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.004 · Cited by 45
Arish, N., Petukhov, D., & Wallach‐Dayan, S. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122996 · Cited by 47
“Short telomeres are a risk factor for IPF [51].”
BackgroundLv, X., Liu, C., Liu, S., Li, Y., Wang, W., Li, K., Hua, F., Cui, B., Zhang, X., Yu, J., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.015 · Cited by 50
Metadata
- Authors
- Alder, J. K., Chen, J. J.-L., Lancaster, L., Danoff, S., Su, S.-C., Cogan, J. D., Vulto, I., Xie, M., Qi, X., Tuder, R. M., Phillips, J. A., Lansdorp, P. M., Loyd, J. E., & Armanios, M. Y.
- Affiliations
- Johns Hopkins University (US)
- Arizona State University (US)
- Vanderbilt University (US)
- BC Cancer Agency (CA)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-09-02
- Volume
- 105
- Issue
- 35
- Pages
- 13051-13056
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2529100
- OpenAlex
- W2147238277
- Cited by
- 805
- References
- 35
- Citations by year
- 2026: 32 · 2025: 40 · 2024: 38 · 2023: 48 · 2022: 45 · 2021: 61 · 2020: 53 · 2019: 60 · 2018: 54 · 2017: 40 · 2016: 36 · 2015: 56 · 2014: 45 · 2013: 45 · 2012: 40
- FWCI
- 33.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Doris Duke Charitable Foundation
- Johns Hopkins University
- National Institutes of Health
- U.S. Public Health Service (T32 60441, K08 118416)
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, idiopathic interstitial pneumonia, telomere length, short telomeres, telomerase mutations, hTERT, hTR, leukocytes, alveolar epithelial cells, cryptogenic cirrhosis, disease risk
- MeSH terms
- Epithelium, Family, Fibrosis, Heterozygote, Humans, Leukocytes, Mononuclear, Pulmonary Alveoli, Pulmonary Fibrosis, Risk Factors, RNA, Tomography, X-Ray Computed, Biomarkers, Case-Control Studies, Telomere, In Situ Hybridization, Fluorescence, Germ-Line Mutation, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.